These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sirtuin1 in tracheal aspirate leukocytes: possible role in the development of bronchopulmonary dysplasia in premature infants. Mody K; Saslow JG; Kathiravan S; Eydelman R; Bhat V; Stahl GE; Pyon K; Bhandari V; Aghai ZH J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1483-7. PubMed ID: 22272724 [TBL] [Abstract][Full Text] [Related]
4. Peptide growth factors in tracheal aspirates of mechanically ventilated preterm neonates. Ambalavanan N; Novak ZE Pediatr Res; 2003 Feb; 53(2):240-4. PubMed ID: 12538781 [TBL] [Abstract][Full Text] [Related]
5. Dexamethasone therapy in preterm infants developing bronchopulmonary dysplasia: effect on pulmonary surfactant disaturated-phosphatidylcholine kinetics. Cogo PE; Simonato M; Mariatoffolo G; Stefanutti G; Chierici M; Cobelli C; Ori C; Carnielli VP Pediatr Res; 2008 Apr; 63(4):433-7. PubMed ID: 18356753 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 -1082 G/A polymorphism and risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants. Yanamandra K; Boggs P; Loggins J; Baier RJ Pediatr Pulmonol; 2005 May; 39(5):426-32. PubMed ID: 15678510 [TBL] [Abstract][Full Text] [Related]
7. Clara cell secretory protein in tracheobronchial aspirates and umbilical cord serum of extremely premature infants with systemic inflammation. Thomas W; Seidenspinner S; Kawczyńska-Leda N; Chmielnicka-Kopaczyk M; Marx A; Wirbelauer J; Szymankiewicz M; Speer CP Neonatology; 2010; 97(3):228-34. PubMed ID: 19887851 [TBL] [Abstract][Full Text] [Related]
8. IFN-γ and IP-10 in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia. Aghai ZH; Saslow JG; Mody K; Eydelman R; Bhat V; Stahl G; Pyon K; Bhandari V Pediatr Pulmonol; 2013 Jan; 48(1):8-13. PubMed ID: 22431160 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-4 and 13 concentrations in infants at risk to develop Bronchopulmonary Dysplasia. Baier RJ; Loggins J; Kruger TE BMC Pediatr; 2003 Aug; 3():8. PubMed ID: 12925236 [TBL] [Abstract][Full Text] [Related]
10. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants. Yoder BA; Harrison M; Clark RH Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192 [TBL] [Abstract][Full Text] [Related]
11. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone. Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 balance in the lungs of preterm infants who develop bronchopulmonary dysplasia. Kakkera DK; Siddiq MM; Parton LA Biol Neonate; 2005; 87(2):82-90. PubMed ID: 15539764 [TBL] [Abstract][Full Text] [Related]
13. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia. Baier RJ; Majid A; Parupia H; Loggins J; Kruger TE Pediatr Pulmonol; 2004 Feb; 37(2):137-48. PubMed ID: 14730659 [TBL] [Abstract][Full Text] [Related]
14. Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Farhath S; He Z; Nakhla T; Saslow J; Soundar S; Camacho J; Stahl G; Shaffer S; Mehta DI; Aghai ZH Pediatrics; 2008 Feb; 121(2):e253-9. PubMed ID: 18245400 [TBL] [Abstract][Full Text] [Related]
15. Surfactant kinetics in preterm infants on mechanical ventilation who did and did not develop bronchopulmonary dysplasia. Cogo PE; Zimmermann LJ; Pesavento R; Sacchetto E; Burighel A; Rosso F; Badon T; Verlato G; Carnielli VP Crit Care Med; 2003 May; 31(5):1532-8. PubMed ID: 12771629 [TBL] [Abstract][Full Text] [Related]
16. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease. Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766 [TBL] [Abstract][Full Text] [Related]
17. Lower parathyroid hormone-related protein content of tracheal aspirates in very low birth weight infants who develop bronchopulmonary dysplasia. Rehan VK; Torday JS Pediatr Res; 2006 Aug; 60(2):216-20. PubMed ID: 16864707 [TBL] [Abstract][Full Text] [Related]
18. Postnatal steroids for the treatment of bronchopulmonary dysplasia: a complex case presentation. Forest S J Perinat Neonatal Nurs; 2011; 25(3):283-91; quiz 292-3. PubMed ID: 21825919 [TBL] [Abstract][Full Text] [Related]
19. Increase in cord blood soluble E-selectin and tracheal aspirate neutrophils at birth and the development of new bronchopulmonary dysplasia. Kim BI; Lee HE; Choi CW; Jo HS; Choi EH; Koh YY; Choi JH J Perinat Med; 2004; 32(3):282-7. PubMed ID: 15188806 [TBL] [Abstract][Full Text] [Related]
20. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study. Ballard HO; Anstead MI; Shook LA Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]